The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating o ...

The United States Congress passed spending legislation early on Saturday, minutes after the funding's expiration, which could ...

Lilly and Novo still dominate the market for weight-loss and diabetes drugs, but the race is heating up in more ways than one ...

The U.S. Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...

Honda and Nissan begin merger talks with a plan for the combination to be completed in 2026, Qualcomm scores a victory in its ...

Two U.S. Navy pilots ejected from their jet fighter over the Red Sea after being caught in "an apparent case of friendly-fire," U.S. Central Command said Sunday, as American forces conducted a new ...

Hopes for a 'Santa Claus' rally looked to be alive again on Monday as S&P 500 futures also were climbing and Nasdaq 100 futures gained in premarket trading.

The Japanese c ...

In a recent head-to-head study involving Novo Nordisk 's Wegovy, Zepbound came out on top, resulting in average weight loss ...

In another milestone, Eli Lilly's weight-loss medication, Zepbound, received FDA approval, marking it as the first drug to specifically tackle moderate to severe obstructive sleep apnea in obese ...

Already established as cornerstone therapies in diabetes and obesity, GLP-1 receptor agonists have now cracked into the ...